Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest CARTO Stories

2013-01-24 12:26:54

SWINDON, England, January 24, 2013 /PRNewswire/ -- Vygon (UK) Ltd has launched an innovative new ECG product designed to help reduce both the patients' and clinicians' exposure to X-ray radiation and enhance therapy. Nautilus(R) [http://www.vygon.co.uk/products/group/piccs ] helps you find your way during catheter insertion by providing accurate, real-time tip location confirmation. (Photo: http://photos.prnewswire.com/prnh/20130123/589298 ) Thousands of peripherally...

2011-05-05 06:30:00

ST. LOUIS, May 5, 2011 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) announced today that it has entered into a new strategic collaboration with Biosense Webster, Inc. related to Stereotaxis' rapidly growing Odyssey(TM) Solutions. This agreement marks the broadest and most committed cooperative agreement around Odyssey to date. Under the new agreement, Stereotaxis has granted Biosense Webster global, non-exclusive rights to resell Stereotaxis' Odyssey products, including the market...

2011-01-13 07:00:00

WATERLOO, Belgium, January 13, 2011 /PRNewswire/ -- - THERMOCOOL(R) SMARTTOUCH(TM) Catheter from Biosense Webster Enables Contact Force Sensing in the Ablation of Atrial Fibrillation Biosense Webster, Inc., a Johnson & Johnson company, and a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the successful completion of the first clinical cases with the new THERMOCOOL(R) SMARTTOUCH(TM) Contact Force Sensing Catheter in the European Union,...

2010-11-22 04:55:00

WATERLOO, Belgium, November 22, 2010 /PRNewswire/ -- According to data published last week in Circulation Cardiovascular Quality and Outcomes, patients with a common heart rhythm disorder, called atrial fibrillation, who were treated with catheter ablation using the NaviStar(R)ThermoCool(R) Catheter, reported markedly fewer symptoms and substantially improved quality of life than patients treated with antiarrhythmia drugs at one year. Atrial fibrillation, or AFib as it is more...

2010-11-15 21:38:36

University of Leicester researcher in pioneering procedure at Leicester hospital The world's first remote heart procedure, using a robotic arm alongside 3-D mapping, is due to take place at Glenfield Hospital in Leicester. It comes six months after Dr Andre Ng carried out the first ever remote catheter ablation procedure using the Amigo Robotic Catheter System. Dr Ng, is senior lecturer at the University of Leicester and consultant cardiologist and electrophysiologist at Glenfield Hospital....

2010-07-08 03:59:00

WATERLOO, Belgium, July 8, 2010 /PRNewswire/ -- Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announces that more than 10 patients have now been enrolled in the CLARITY-study ("CLARITY-AF"), comparing the efficacy, safety and efficiency of CARTO(R) 3 System guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) catheter versus fluoroscopy guided radiofrequency ablation using the Pulmonary Vein Ablation catheter(R) (PVAC(R),...

2010-05-13 09:36:00

DIAMOND BAR, California, May 13, 2010 /PRNewswire/ -- Biosense Webster, Inc. will underline its leadership position in the electrophysiology market and underscore its commitment to electrophysiologists and their catheter ablation practices at the 2010 Heart Rhythm Meeting. Heart Rhythm is the most important scientific meeting in the field of Electrophysiology and will be held in Denver, CO, USA from May 12th to 15th. This year, Biosense Webster, Inc. will be showcasing its cutting...

2010-05-13 09:34:00

WATERLOO, Belgium, May 13, 2010 /PRNewswire/ -- - State-of-the-Art Irrigated Ablation Catheter Offers a Unique Design and Industry Leading Cooling Efficiency Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today the completion of the first clinical cases with the new THERMOCOOL(R) SF Irrigated Ablation catheter in the European Union, following recent CE Mark approval. The THERMOCOOL(R) SF catheter is the most advanced...

2010-04-08 12:30:00

WATERLOO, Belgium, April 8, 2010 /PRNewswire/ -- Biosense Webster announces that this week it has obtained its first Ethics Committee approval for the CLARITY study, comparing the 1-year efficacy, safety and efficiency of CARTO(R) 3 System-guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) Catheter versus fluoroscopy-guided radiofrequency ablation using the Pulmonary Vein Ablation Catheter(R) (PVAC(R), Ablation Frontiers, Medtronic) in patients with paroxysmal atrial...

2010-04-08 09:00:00

WATERLOO, Belgium/>, April 8, 2010/> /PRNewswire/ -- Biosense Webster announces that this week it has obtained its first Ethics Committee approval for the CLARITY study, comparing the 1-year efficacy, safety and efficiency of CARTO(R) 3 System-guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) Catheter versus fluoroscopy-guided radiofrequency ablation using the Pulmonary Vein Ablation Catheter(R) (PVAC(R), Ablation Frontiers, Medtronic) in patients with paroxysmal atrial...